These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37238737)

  • 1. The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling.
    Mukherjee S; Chakraborty M; Haubner J; Ernst G; DePasquale M; Carpenter D; Barrow JC; Chakraborty A
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway.
    Ghoshal S; Zhu Q; Asteian A; Lin H; Xu H; Ernst G; Barrow JC; Xu B; Cameron MD; Kamenecka TM; Chakraborty A
    Mol Metab; 2016 Oct; 5(10):903-917. PubMed ID: 27689003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
    Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
    Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice.
    Tanaka Y; Nagoshi T; Takahashi H; Oi Y; Yoshii A; Kimura H; Ito K; Kashiwagi Y; Tanaka TD; Yoshimura M
    Mol Metab; 2022 Jan; 55():101411. PubMed ID: 34863940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
    Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
    Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.
    Lee MR; Yang HJ; Park KI; Ma JY
    Phytomedicine; 2019 Mar; 55():14-22. PubMed ID: 30668424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice.
    Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T
    J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain.
    Zhu Q; Ghoshal S; Tyagi R; Chakraborty A
    Mol Metab; 2017 Jan; 6(1):73-85. PubMed ID: 28123939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver disease.
    Secor JD; Cho BS; Yu LJ; Pan A; Ko VH; Dao DT; Feigh M; Anez-Bustillos L; Fell GL; Fraser DA; Gura KM; Puder M
    Lipids; 2022 Jul; 57(4-5):241-255. PubMed ID: 35778847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice.
    Chang TC; Chiang H; Lai YH; Huang YL; Huang HC; Liang YC; Liu HK; Huang C
    BMC Complement Altern Med; 2019 Dec; 19(1):368. PubMed ID: 31836013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
    Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
    Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-targeting strategy to ameliorate high-fat-diet- and fructose-induced (western diet-induced) non-alcoholic fatty liver disease (NAFLD) with supplementation of a mixture of legume ethanol extracts.
    Koh YC; Lin YC; Lee PS; Lu TJ; Lin KY; Pan MH
    Food Funct; 2020 Sep; 11(9):7545-7560. PubMed ID: 32815965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotadutide effect in liver and adipose tissue in obese mice.
    Marcondes-de-Castro IA; Oliveira TF; Spezani R; Marinho TS; Cardoso LEM; Aguila MB; Mandarim-de-Lacerda CA
    J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36753306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
    Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
    J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation by Tetrahydrocurcumin of Adiposity and Hepatic Steatosis in Mice with High-Fat-Diet-Induced Obesity.
    Pan MH; Chen JW; Kong ZL; Wu JC; Ho CT; Lai CS
    J Agric Food Chem; 2018 Dec; 66(48):12685-12695. PubMed ID: 30415544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Isoliquiritigenin at a Low Dose Ameliorates Insulin Resistance and NAFLD in Diet-Induced Obesity in C57BL/6J Mice.
    Lee Y; Kwon EY; Choi MS
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30360437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.